Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Work In Process (2016 - 2019)

Aptevo Therapeutics' Work In Process history spans 5 years, with the latest figure at $2.0 million for Q4 2019.

  • For Q4 2019, Work In Process rose 113.76% year-over-year to $2.0 million; the TTM value through Dec 2019 reached $2.0 million, up 113.76%, while the annual FY2019 figure was $2.0 million, 113.76% up from the prior year.
  • Work In Process for Q4 2019 was $2.0 million at Aptevo Therapeutics, down from $5.5 million in the prior quarter.
  • Across five years, Work In Process topped out at $5.9 million in Q2 2019 and bottomed at $4000.0 in Q4 2016.
  • The 5-year median for Work In Process is $1.8 million (2016), against an average of $2.5 million.
  • The largest annual shift saw Work In Process tumbled 99.92% in 2016 before it surged 11950.0% in 2017.
  • A 5-year view of Work In Process shows it stood at $4.7 million in 2015, then crashed by 99.92% to $4000.0 in 2016, then soared by 11950.0% to $482000.0 in 2017, then soared by 90.04% to $916000.0 in 2018, then surged by 113.76% to $2.0 million in 2019.
  • Per Business Quant, the three most recent readings for APVO's Work In Process are $2.0 million (Q4 2019), $5.5 million (Q3 2019), and $5.9 million (Q2 2019).